Maps Laboratories

Rajkot, India
Manufacturing and exporting of pharmaceutical bulk drugs and formulations in India.
Annual revenue $5.5M Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Maps Laboratories

Maps Laboratories is a company based in Rajkot (India). Maps Laboratories offers products and services including Gabapentin and Pregabalin.

  • Headquarter Rajkot, India
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Legal Name Maps Laboratories Pvt. Ltd
  • Jurisdiction Dist Rajkot, Gujarat, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $5.46 M (USD)
    2.77
    as on Mar 31, 2023
  • Net Profit
    $45.39 K (USD)
    -20.14
    as on Mar 31, 2023
  • EBITDA
    $90.47 K (USD)
    -41.73
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Maps Laboratories

Maps Laboratories offers a comprehensive portfolio of products and services, including Gabapentin and Pregabalin.

Product name locked
Category locked
Primary

Gabapentin is manufactured as a bulk drug and formulation product for pharmaceutical applications.

Product name locked
Category locked
Locked

Pregabalin is produced as part of the range of bulk drugs and intermediates for medical uses.

Funding Insights of Maps Laboratories

Premium access

Detailed funding history for Maps Laboratories

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Maps Laboratories

Investments
Premium access

Investment portfolio details for Maps Laboratories

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Maps Laboratories

Premium access

Detailed financials for Maps Laboratories

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Maps Laboratories Comparisons

Maps Laboratories Primary company
Description
Manufacturing and exporting of pharmaceutical bulk drugs and...
Location
Rajkot, India
Founded Year
-
Annual Revenue
$5.46 M (USD)
Net Profit
$45.39 K (USD)
EBITDA
$90.47 K (USD)
Employees
Not available
Premium access

Peer comparison for Maps Laboratories

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Maps Laboratories

Premium access

Detailed competitors of Maps Laboratories

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Maps Laboratories

Premium access

Complete news archive for Maps Laboratories

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Maps Laboratories

Maps Laboratories is headquartered in Rajkot, India. It is registered at Rajkot, Gujarat, India.

Annual revenue of Maps Laboratories is $5.46M as on Mar 31, 2023.

Maps Laboratories was established in 1999 and is engaged in the manufacturing and exporting of a wide range of bulk drugs and formulation products, including Gabapentin and Pregabalin. It is recognized for its qualitative Active Pharmaceutical Ingredients, with operations led under the direction of Mr. Rupesh Patel as CEO. A mission to provide innovative APIs for global healthcare is pursued, along with a vision for high-quality production that adheres to ethical standards. Manufacturing occurs across multiple plants in Gujarat, India, focusing on contributions to healthcare through research-based excellence. Client feedback highlights practical tools and methods offered by the company.

Maps Laboratories offers Gabapentin and Pregabalin.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available